Literature DB >> 11063221

Microsatellite instability in gallbladder carcinoma: two independent genetic pathways of gallbladder carcinogenesis.

T Yoshida1, T Sugai, W Habano, S Nakamura, N Uesugi, O Funato, K Saito.   

Abstract

Although the genetic basis for gallbladder carcinogenesis has not been clarified, considerable evidence has shown that genetic alterations play an important role in the development and progression of human cancers. In this study, we analyzed 30 gallbladder carcinomas to investigate the role of genetic alterations in their tumorigenesis, and to study correlations with their clinicopathological features. Tissue samples were obtained from 30 patients with gallbladder carcinoma (11 men and 19 women; mean age, 62 years; age range, 38-80 years). Genomic DNAs were extracted from fresh tumor tissue. We examined loss of heterozygosity (LOH) in the p53, APC, DCC, RB, and NM23-H1 gene regions by polymerase chain reaction (PCR)-LOH assay using an automated fluorescent DNA sequencer employing four microsatellite markers (p53, APC, DCC, NM23-H1). Five additional microsatellite markers were used for the determination of microsatellite instability (MSI). LOH was found at p53 in 9 of 15 informative cases (60%), at DCC in 10 of 22 (45%), at APC in 5 of 15 (33%), at RB in 1 of 8 (13%), and at NM23-H1 in 1 of 15 (7%). MSI was observed in 5 of 30 cases (17%) in at least one chromosomal loci of these nine microsatellite markers. None of the patients with MSI-positive tumors showed lymph node metastasis, and there was an inverse correlation between MSI and the presence of LOH in gallbladder carcinoma. These results suggest that there are two independent genetic pathways in gallbladder carcinogenesis; that is, an MSI pathway and an LOH pathway.

Entities:  

Mesh:

Year:  2000        PMID: 11063221     DOI: 10.1007/s005350070036

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  8 in total

1.  Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary.

Authors:  Masayuki Nagahashi; Yoichi Ajioka; Istvan Lang; Zoltan Szentirmay; Miklos Kasler; Hiroto Nakadaira; Naoyuki Yokoyama; Gen Watanabe; Ken Nishikura; Toshifumi Wakai; Yoshio Shirai; Katsuyoshi Hatakeyama; Masaharu Yamamoto
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

2.  Gastrointestinal stromal tumor with synchronous gallbladder adenocarcinoma.

Authors:  Julio A Diaz-Perez; Melina Mastrodimos; Abhinay Reddy
Journal:  J Gastrointest Cancer       Date:  2014-09

3.  Infrequent mismatch repair protein loss in gallbladder cancer patients in Japan.

Authors:  Hiroshi Yoshida; Kazuaki Shimada; Nobuyoshi Hiraoka
Journal:  Virchows Arch       Date:  2016-11-18       Impact factor: 4.064

4.  Microsatellite instability in gallbladder carcinoma.

Authors:  Andrea P Moy; Mohammad Shahid; Cristina R Ferrone; Darrell R Borger; Andrew X Zhu; David Ting; Vikram Deshpande
Journal:  Virchows Arch       Date:  2015-02-14       Impact factor: 4.064

Review 5.  Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches.

Authors:  Margherita Ratti; Andrea Lampis; Jens C Hahne; Rodolfo Passalacqua; Nicola Valeri
Journal:  Cell Mol Life Sci       Date:  2018-09-01       Impact factor: 9.261

Review 6.  A genetic model for gallbladder carcinogenesis and its dissemination.

Authors:  S G Barreto; A Dutt; A Chaudhary
Journal:  Ann Oncol       Date:  2014-04-04       Impact factor: 32.976

Review 7.  Hypermutation and microsatellite instability in gastrointestinal cancers.

Authors:  Kizuki Yuza; Masayuki Nagahashi; Satoshi Watanabe; Kazuaki Takabe; Toshifumi Wakai
Journal:  Oncotarget       Date:  2017-12-01

8.  Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma.

Authors:  You-Na Sung; Sung Joo Kim; Sun-Young Jun; Changhoon Yoo; Kyu-Pyo Kim; Jae Hoon Lee; Dae Wook Hwang; Shin Hwang; Sang Soo Lee; Seung-Mo Hong
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.